Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 5397  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed256    
    Printed7    
    Emailed0    
    PDF Downloaded18    
    Comments [Add]    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2019  |  Volume : 67  |  Issue : 3  |  Page : 728--731

Hyperbaric oxygen therapy in patients with hypoxic ischemic encephalopathy


1 Department of Physical Medicine and Rehabilitation, Hyperbaric Medicine Division, Amrita Institute of Medical Sciences, Cochin, Kerala, India
2 Department of Neurology, Amrita Institute of Medical Sciences, Cochin, Kerala, India
3 Department of Biostatistics, Amrita Institute of Medical Sciences, Cochin, Kerala, India

Correspondence Address:
Dr. Ravi Sankaran
Department of Physical Medicine and Rehabilitation, Hyperbaric Medicine Division, Amrita Institute of Medical Sciences, Cochin - 682 041, Kerala
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.263236

Rights and Permissions

Background and Aim: To assess the efficacy of hyperbaric oxygen therapy (HBOT) in patients with hypoxic ischemic encephalopathy (HIE). Design: Non-randomized case-control observational study. Setting: Tertiary level neurorehabilitation unit. Population: Twenty-five patients with HIE seen between 1 to 12 months after the injury and having a coma recovery scale-revised (CRS-R) score less than 7 at entry were recruited. Methods: Out of the patients who received HBOT, 20 received 20 sessions of HBOT at two absolute atmosphere pressure (ATA), and two received 60 sessions at 2 ATA over three different treatment intervals. We compared the outcomes between cases (who received HBOT) and controls (who did not receive HBOT).Cases and controls were allocated to three groups based on the time interval after injury following which they were recruited to the study: 1–3 months (9 cases and 16 controls), 4–8 months (9 cases and 9 controls) and 9–12 months (8 cases and 3 controls). Outcome Measures: CRS-R, Karnofsky performance scale, and change in disorder of consciousness (DOC) at admission and discharge were assessed. Results: We observed a significant difference in CRS-R favoring the HBOT group at time intervals of 1–3 and 4–8 months. More patients in the HBOT group improved in DOC than the control group. Conclusions: HBOT given in the first nine months post-HIE can result in a better recovery and functional outcome.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow